About PAL
Staff
PAL Coalition
Lawyers
Funders
Leadership Circle
Directing cy pres awards to PAL and Community Catalyst
Internship Opportunities
Current Lawsuits
Past Lawsuits
Settlements
Suggest a New Case
FAQ
Amicus Briefs
Cy Pres
Press Releases
Press Coverage
Media Inquiries
Copay coupons
Generic Drugs
Pay-for-Delay Settlements
Direct-to-Consumer-Advertising (DTCA)
Prescription Access and Quality (Community Catalyst)
Drug Pricing
Pharmacy Benefit Managers
Newsletters
Articles
Amicus Briefs
Testimony & Comments
Brochure (.pdf)
Current Members
How to Join
PAL Blog
Health Policy Hub
Postscript
Press Releases
Press Coverage
Media Inquiries
Get updates on drug lawsuits, settlements and PAL news
Recent Press Releases
Consumer groups applaud tough new FDA standards for TV drug ads
PAL and 22 other stakeholder groups support long-delayed consumer protections, call for new standards to make ads less distracting and propose fines for bad ads
06/25/2010
Final Settlement of Two Conspiracy Lawsuits Rolls Back Prices on Hundreds of Drugs, Saving Billions in Future Prescription Drug Costs
Up to $1 Billion in Rx Drug Savings Expected
03/19/2009
Generics Are Powerful Medicine Announces National Grant Recipients
11 Consumer Organizations to Receive Funds & Support to Educate Consumers on The Safety, Value and Effectiveness of Generic Drugs
05/20/2008
Newly-Unsealed Documents Shed Light on Abbott Laboratories' 400% Norvir Price Hike
05/12/2008
PAL joins "friend of the Court" brief supporting new U.S. Patent Rules
12/20/2007
MORE PRESS RELEASES »
Recent Press Coverage
Drug Coupon Use Soars, Prompting Safety and Spending Concerns (Bloomberg)
Article by Anna Edney, Oct 28, 2010, noting how drug coupon use has grown significantly, threatening to drive up health care costs.
05/22/2012
Coupon Study Could Drag FDA into Drug Pricing, Regulatory Change Possible
By Alaina Busch, InsideHealthReform, Jan. 20, 2011. PAL Director Wells Wilkinson interviewed on FDA authority to regulate drug coupons.
05/22/2012
Drug makers agree to $125M settlement
Eleven pharmaceutical corporations have agreed to pay $125 million to settle allegations that they deliberately inflated average wholesale prices on Medicare Part B drugs.
03/13/2008
Price of Prescriptions Tough to Swallow
We need to stop treating prescription drugs like shampoo and fabric softener," said Alex Sugerman-Brozan, the director of the Prescription Access Litigation Project. "These are not just consumer products, they're medical treatments."
03/26/2008
Bracing for a Showdown
Average manufacturer price is dead, or is it? Two months after a Federal District Court Judge granted a temporary restraining order, preventing the Centers for Medicare and Medicaid Services from implementing the new generic drug reimbursement model for Medicaid, the future of the reimbursement plan remains up in the air. Still, while it is unclear how or when the case will be resolved, most pharmacy experts agree that pharmacists will continue to see tightening in prescription drug reimbursement.
02/11/2008
MORE PRESS COVERAGE »
